<?xml version="1.0" encoding="UTF-8"?>
<ClinicalDocument xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <realmCode code="US"/>
  <typeId root="2.16.840.1.113883.1.3" extension="POCD_HD000040"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.1" extension="2015-08-01"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.9" extension="2015-08-01"/>
  <id root="463ecb14-f9cb-4b79-895a-adc67332e12f"/>
  <code code="11506-3" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="Progress note"/>
  <title>SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Frédéric Chopin — True-date frame: synthetic events are moved into the patient&apos;s historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.</title>
  <effectiveTime value="18380320120000-0500"/>
  <confidentialityCode code="N" codeSystem="2.16.840.1.113883.5.25"/>
  <languageCode code="en-US"/>
  <setId root="0dbaa1ce-69bf-4974-9ba1-ba1d1aad0ddf"/>
  <versionNumber value="1"/>
  <recordTarget>
    <patientRole>
      <id root="3b7655ed-b522-485f-ade3-a54d9884e453" extension="HR-NI020-SYN-TD"/>
      <id root="2.16.840.1.113883.4.1" extension="000-20-8845"/>
      <addr nullFlavor="UNK"/>
      <telecom nullFlavor="UNK"/>
      <patient>
        <name use="L"><given>Frédéric</given><family>Chopin</family></name>
        <administrativeGenderCode code="M" codeSystem="2.16.840.1.113883.5.1" displayName="Male"/>
        <birthTime value="18100301"/>
        <raceCode nullFlavor="ASKU"/>
        <ethnicGroupCode nullFlavor="ASKU"/>
        <languageCommunication><languageCode code="en"/><preferenceInd value="true"/></languageCommunication>
      </patient>
      <providerOrganization>
        <id root="6a7f851b-842b-45d7-9552-3e8582647414"/>
        <name>St. Posthumous Health Center</name>
      <telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr>
      </providerOrganization>
    </patientRole>
  </recordTarget>
  <author>
    <time value="18380320120000-0500"/>
    <assignedAuthor><id root="138b4347-1894-46c1-b2d0-01900affe467"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Matthias</given><family>Lindqvist</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedAuthor>
  </author>
  <custodian>
    <assignedCustodian><representedCustodianOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedCustodianOrganization></assignedCustodian>
  </custodian>
  <legalAuthenticator>
    <time value="18380320120000-0500"/>
    <signatureCode code="S"/>
    <assignedEntity><id root="138b4347-1894-46c1-b2d0-01900affe467"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Matthias</given><family>Lindqvist</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity>
  </legalAuthenticator>
  <documentationOf>
    <serviceEvent classCode="PCPR"><templateId root="2.16.840.1.113883.10.20.21.3.1"/><effectiveTime><low value="18380320"/><high value="18380320"/></effectiveTime><performer typeCode="PRF"><assignedEntity><id root="138b4347-1894-46c1-b2d0-01900affe467"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Matthias</given><family>Lindqvist</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></performer></serviceEvent>
  </documentationOf>
  <componentOf>
    <encompassingEncounter>
      <id root="5c9e8945-948a-405b-820b-3cbee15aa9b6"/>
      <code code="390906007" codeSystem="2.16.840.1.113883.6.96" displayName="Follow-up encounter"><originalText>Results visit: pulmonary tuberculosis confirmed; infectious diseases consultation and the start of the four-month rifapentine-moxifloxacin regimen by video-observed therapy</originalText></code>
      <effectiveTime><low value="18380320"/><high value="18380320"/></effectiveTime>
      <encounterParticipant typeCode="ATND"><assignedEntity><id root="138b4347-1894-46c1-b2d0-01900affe467"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Matthias</given><family>Lindqvist</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></encounterParticipant>
      <location><healthCareFacility><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><serviceProviderOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></serviceProviderOrganization></healthCareFacility></location>
    </encompassingEncounter>
  </componentOf>
  <component>
    <structuredBody>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.1.13.2.1"/>
    <code code="10154-3" codeSystem="2.16.840.1.113883.6.1" displayName="Chief complaint Narrative - Reported"/>
    <title>Chief Complaint</title>
    <text><paragraph>Results visit: tuberculosis confirmed; infectious diseases consultation and start of treatment. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.4"/>
    <code code="10164-2" codeSystem="2.16.840.1.113883.6.1" displayName="History of Present illness Narrative"/>
    <title>History of Present Illness</title>
    <text><paragraph>Mr. Chopin returns three days after his first visit, masked and seen in an airborne infection isolation room, for his results; Dr. Kowalczyk-Grant of infectious diseases sees him the same morning. He has stayed at home with no students or visitors, and his lessons have moved online. His cough and night sweats are unchanged, and he has coughed up streaks of blood once since the first visit. His three sputum smears show acid-fast bacilli (2+, 2+, and 1+), and the nucleic acid amplification test on the first sample detected Mycobacterium tuberculosis complex with no rifampin resistance; molecular tests for isoniazid and fluoroquinolone resistance and the cultures are pending. The interferon-gamma release assay is positive, HIV is negative, hepatitis B surface antigen and core antibody are negative with surface antibody positive from vaccination, and hepatitis C antibody is negative. He was relieved to have a name for the illness and asked how long treatment lasts and when he can teach again. After the four-month and six-month regimens were explained, he chose the four-month regimen and took his first observed dose with a meal in the clinic. [S]</paragraph><table><thead><tr><th>Element</th><th>Detail</th></tr></thead><tbody><tr><td>Results</td><td>Smears 2+, 2+, 1+; amplification test positive without rifampin resistance; IGRA positive; HIV negative; hepatitis B immune; hepatitis C negative</td></tr><tr><td>Symptoms</td><td>Cough, one more streak of blood, night sweats</td></tr><tr><td>Decision</td><td>Four-month rifapentine-moxifloxacin regimen, first dose today</td></tr><tr><td>Isolation</td><td>At home; lessons online</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.18"/>
    <code code="10187-3" codeSystem="2.16.840.1.113883.6.1" displayName="Review of systems Narrative - Reported"/>
    <title>Review of Systems</title>
    <text><table><thead><tr><th>System</th><th>Result</th><th>Finding</th></tr></thead><tbody><tr><td>Respiratory</td><td>Positive</td><td>Cough with morning sputum; one more streak of blood since the first visit; no breathlessness at rest</td></tr><tr><td>Constitutional</td><td>Positive</td><td>Night sweats and evening fevers; poor appetite</td></tr><tr><td>Musculoskeletal</td><td>Negative</td><td>No tendon or joint pain</td></tr><tr><td>Neurological</td><td>Negative</td><td>No numbness or tingling; fine finger movements normal</td></tr><tr><td>Psychiatric</td><td>Positive</td><td>Anxious and low, but relieved to know the diagnosis; no thoughts of suicide or self-harm</td></tr></tbody></table><paragraph>5 systems reviewed. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.1" extension="2014-06-09"/><templateId root="2.16.840.1.113883.10.20.22.2.1.1" extension="2014-06-09"/>
    <code code="10160-0" codeSystem="2.16.840.1.113883.6.1" displayName="History of Medication use Narrative"/>
    <title>Medications</title>
    <text><table><thead><tr><th>Medication</th><th>Frequency</th><th>Route</th><th>Dates</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="medication-1"><td>Rifapentine 150 mg tablets, eight tablets (1200 mg) daily with food</td><td>1200 mg once daily with a meal by video-observed therapy with the health department, seven days a week, for 17 weeks (119 doses)</td><td>Oral route</td><td>1838-03-20 to 1838-07-16</td><td>completed</td><td>S</td></tr><tr ID="medication-2"><td>Moxifloxacin 400 mg tablet, one tablet daily</td><td>400 mg once daily with the other drugs by video-observed therapy with the health department, seven days a week, for 17 weeks; no mineral supplements within 4 hours before or 8 hours after</td><td>Oral route</td><td>1838-03-20 to 1838-07-16</td><td>completed</td><td>S</td></tr><tr ID="medication-3"><td>Isoniazid 300 mg tablet, one tablet daily</td><td>300 mg once daily by video-observed therapy with the health department, seven days a week, for 17 weeks</td><td>Oral route</td><td>1838-03-20 to 1838-07-16</td><td>completed</td><td>S</td></tr><tr ID="medication-4"><td>Pyrazinamide 500 mg tablets, two tablets (1000 mg) daily</td><td>1000 mg once daily by video-observed therapy with the health department, seven days a week, for the eight-week intensive phase (weight band 40 to under 55 kg)</td><td>Oral route</td><td>1838-03-20 to 1838-05-14</td><td>completed</td><td>S</td></tr><tr ID="medication-5"><td>Vitamin B6 (pyridoxine) 50 mg tablet, one tablet daily</td><td>50 mg once daily with isoniazid</td><td>Oral route</td><td>1838-03-20 to 1838-07-16</td><td>completed</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="1748953d-e4e2-4efb-bf30-36ad3cedfe24"/>
      <text><reference value="#medication-1"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="18380320"/><high value="18380716"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1200" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="242671" codeSystem="2.16.840.1.113883.6.88" displayName="rifapentine 150 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="4fa33ec2-6bef-447c-afbd-6b1b33d7e15d"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="A15.0" codeSystem="2.16.840.1.113883.6.90" displayName="Tuberculosis of lung"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="d5a591a9-acc9-441c-a2be-855ea6227b4b"/>
      <text><reference value="#medication-2"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="18380320"/><high value="18380716"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="400" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="311787" codeSystem="2.16.840.1.113883.6.88" displayName="moxifloxacin 400 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="adfc8759-8cae-4e9a-8c22-086b346bccd9"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="A15.0" codeSystem="2.16.840.1.113883.6.90" displayName="Tuberculosis of lung"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="dbda3077-514d-4a45-b836-3a9096acdfb7"/>
      <text><reference value="#medication-3"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="18380320"/><high value="18380716"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="300" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="197832" codeSystem="2.16.840.1.113883.6.88" displayName="isoniazid 300 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="bf19d6d8-4202-4038-aec3-d79599caf92d"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="A15.0" codeSystem="2.16.840.1.113883.6.90" displayName="Tuberculosis of lung"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="fb6ba3b2-daaa-4b55-94e0-31fa689722a7"/>
      <text><reference value="#medication-4"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="18380320"/><high value="18380514"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1000" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="198181" codeSystem="2.16.840.1.113883.6.88" displayName="pyrazinamide 500 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="c9d7dd8e-5e3d-459b-bb76-d68001f23f4b"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="A15.0" codeSystem="2.16.840.1.113883.6.90" displayName="Tuberculosis of lung"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="ed86835c-155c-48a8-b94e-22413c68343a"/>
      <text><reference value="#medication-5"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="18380320"/><high value="18380716"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="50" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="639566" codeSystem="2.16.840.1.113883.6.88" displayName="vitamin B6 50 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="7b665376-b799-4123-956f-f5a59e6359d8"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="A15.0" codeSystem="2.16.840.1.113883.6.90" displayName="Tuberculosis of lung"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.6" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.6.1" extension="2015-08-01"/>
    <code code="48765-2" codeSystem="2.16.840.1.113883.6.1" displayName="Allergies and adverse reactions Document"/>
    <title>Allergies and Intolerances</title>
    <text><table><thead><tr><th>Allergy</th><th>Reaction</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="allergy-1"><td>No known allergy</td><td></td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.30" extension="2015-08-01"/>
      <id root="78a9fd2d-c0eb-4857-b6b9-9132b17cd613"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="18380317"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN" negationInd="true">
          <templateId root="2.16.840.1.113883.10.20.22.4.7" extension="2014-06-09"/>
          <id root="d808b674-30a3-4594-84d3-0f92e9346e08"/>
          <code code="ASSERTION" codeSystem="2.16.840.1.113883.5.4"/>
          <text><reference value="#allergy-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low nullFlavor="UNK"/></effectiveTime>
          <value xsi:type="CD" code="419199007" codeSystem="2.16.840.1.113883.6.96" displayName="Allergy to substance"/>
          <participant typeCode="CSM"><participantRole classCode="MANU"><playingEntity classCode="MMAT"><code nullFlavor="NA"/></playingEntity></participantRole></participant>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.4" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.4.1" extension="2015-08-01"/>
    <code code="8716-3" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs"/>
    <title>Vital Signs</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="vital-2-1"><td>1838-03-20</td><td>Body height</td><td>170</td><td>cm</td><td>S</td></tr>
  <tr ID="vital-2-2"><td>1838-03-20</td><td>Body weight</td><td>48.4</td><td>kg</td><td>S</td></tr>
  <tr ID="vital-2-3"><td>1838-03-20</td><td>Body mass index (BMI) [Ratio]</td><td>16.7</td><td>kg/m2</td><td>S</td></tr>
  <tr ID="vital-2-4"><td>1838-03-20</td><td>Systolic blood pressure</td><td>102</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-2-5"><td>1838-03-20</td><td>Diastolic blood pressure</td><td>64</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-2-6"><td>1838-03-20</td><td>Heart rate</td><td>98</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-2-7"><td>1838-03-20</td><td>Respiratory rate</td><td>18</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-2-8"><td>1838-03-20</td><td>Body temperature</td><td>37.6</td><td>Cel</td><td>S</td></tr>
  <tr ID="vital-2-9"><td>1838-03-20</td><td>Oxygen saturation in Arterial blood by Pulse oximetry</td><td>95</td><td>%</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.26" extension="2015-08-01"/>
      <id root="3bb2e5db-a3db-48ce-ab2b-d88cd99805c1"/>
      <code code="74728-7" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs, weight, height, head circumference, oximetry, BMI, and BSA panel - HL7.FHIR.R4"/>
      <statusCode code="completed"/><effectiveTime value="18380320"/>
      <component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="8f9c877b-8326-4f7c-ab04-e7ce04524118"/><code code="8302-2" codeSystem="2.16.840.1.113883.6.1" displayName="Body height"/><text><reference value="#vital-2-1"/></text><statusCode code="completed"/><effectiveTime value="18380320"/><value xsi:type="PQ" value="170" unit="cm"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="5ac9de2d-313b-465c-a6bc-75c628111255"/><code code="29463-7" codeSystem="2.16.840.1.113883.6.1" displayName="Body weight"/><text><reference value="#vital-2-2"/></text><statusCode code="completed"/><effectiveTime value="18380320"/><value xsi:type="PQ" value="48.4" unit="kg"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="5e5f9e99-794f-466a-ac1e-bb4f62f64aeb"/><code code="39156-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body mass index (BMI) [Ratio]"/><text><reference value="#vital-2-3"/></text><statusCode code="completed"/><effectiveTime value="18380320"/><value xsi:type="PQ" value="16.7" unit="kg/m2"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="b7243779-518d-4937-b799-f13f16baa567"/><code code="8480-6" codeSystem="2.16.840.1.113883.6.1" displayName="Systolic blood pressure"/><text><reference value="#vital-2-4"/></text><statusCode code="completed"/><effectiveTime value="18380320"/><value xsi:type="PQ" value="102" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="d5197e9c-7652-44f1-b0ff-b5d37131dcae"/><code code="8462-4" codeSystem="2.16.840.1.113883.6.1" displayName="Diastolic blood pressure"/><text><reference value="#vital-2-5"/></text><statusCode code="completed"/><effectiveTime value="18380320"/><value xsi:type="PQ" value="64" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="00870add-c3d2-49ee-851f-d8f73d9cb24f"/><code code="8867-4" codeSystem="2.16.840.1.113883.6.1" displayName="Heart rate"/><text><reference value="#vital-2-6"/></text><statusCode code="completed"/><effectiveTime value="18380320"/><value xsi:type="PQ" value="98" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="af4fee78-253d-4867-a006-4c292d706f47"/><code code="9279-1" codeSystem="2.16.840.1.113883.6.1" displayName="Respiratory rate"/><text><reference value="#vital-2-7"/></text><statusCode code="completed"/><effectiveTime value="18380320"/><value xsi:type="PQ" value="18" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="f529bd7c-1596-4070-825b-b4cad098939c"/><code code="8310-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body temperature"/><text><reference value="#vital-2-8"/></text><statusCode code="completed"/><effectiveTime value="18380320"/><value xsi:type="PQ" value="37.6" unit="Cel"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="c159e556-eaf2-4715-9ca2-fb33de84b3db"/><code code="59408-5" codeSystem="2.16.840.1.113883.6.1" displayName="Oxygen saturation in Arterial blood by Pulse oximetry"/><text><reference value="#vital-2-9"/></text><statusCode code="completed"/><effectiveTime value="18380320"/><value xsi:type="PQ" value="95" unit="%"/></observation></component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section nullFlavor="NI">
    <templateId root="2.16.840.1.113883.10.20.22.2.3" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.3.1" extension="2015-08-01"/>
    <code code="30954-2" codeSystem="2.16.840.1.113883.6.1"/>
    <title>Results</title>
    <text><paragraph>No results recorded at this visit.</paragraph></text>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.2.10" extension="2015-08-01"/>
    <code code="29545-1" codeSystem="2.16.840.1.113883.6.1" displayName="Physical findings note"/>
    <title>Physical Exam</title>
    <text><paragraph>Vital signs recorded on 1838-03-20; see the Vital Signs section. [S]</paragraph><table><thead><tr><th>System</th><th>Finding</th></tr></thead><tbody><tr><td>General</td><td>Thin and tired; weight 48.4 kg; temperature 37.6 °C, pulse 98; seen in an airborne infection isolation room with a respirator</td></tr><tr><td>Respiratory</td><td>Coarse crackles and bronchial breathing over the right upper zone; fine crackles at the left apex</td></tr><tr><td>Abdomen</td><td>Soft; liver not enlarged</td></tr><tr><td>Musculoskeletal</td><td>Achilles and wrist tendons non-tender, as a baseline before moxifloxacin</td></tr><tr><td>Neurological</td><td>Normal light touch and vibration in the fingers and feet, as a baseline before isoniazid</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.5" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.5.1" extension="2015-08-01"/>
    <code code="11450-4" codeSystem="2.16.840.1.113883.6.1" displayName="Problem List"/>
    <title>Problems</title>
    <text><table><thead><tr><th>Problem</th><th>Clinical status</th><th>Verification</th><th>Code</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="problem-1">
    <td>Cough for about three months, blood-streaked sputum for two weeks, night sweats, and weight loss of about 6 kg in a man of 28, with a right upper lobe cavity on chest X-ray and CT: suspected pulmonary tuberculosis; home airborne isolation and three sputum samples for acid-fast smear, nucleic acid amplification, and culture</td><td>resolved</td><td>confirmed</td>
    <td>R04.2</td><td>S — Synthetic presenting problem linked to his documented chronic cough and hemoptysis; superseded by the diagnosis at the second visit.</td>
  </tr>
  <tr ID="problem-2">
    <td>Pulmonary tuberculosis of the right upper lobe, cavitary and sputum smear-positive, confirmed by nucleic acid amplification without rifampin resistance</td><td>active</td><td>confirmed</td>
    <td>A15.0</td><td>S — Synthetic modern coding of his documented tuberculosis, chosen over the disputed genetic and cardiac alternatives; the cavity and all bacteriology are synthetic.</td>
  </tr>
  <tr ID="problem-3">
    <td>Moderate protein-calorie malnutrition: BMI 16.8, about 11 percent weight loss in three months, and albumin 3.2 g/dL</td><td>active</td><td>confirmed</td>
    <td>E44.0</td><td>S — Synthetic nutrition diagnosis anchored to his documented frailty and exhaustion.</td>
  </tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="7273f904-2f9f-43fc-b51b-1de29ca555bc"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="18380317"/><high value="18380320"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="9c332de1-f7fc-49ea-ab9e-76c294ab655b"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="18380317"/><high value="18380320"/></effectiveTime>
          <value xsi:type="CD" code="R04.2" codeSystem="2.16.840.1.113883.6.90" displayName="Hemoptysis"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="5826947b-f17a-4a6e-b4df-c3d40173e109"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="18380320"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="79d9a1d2-506b-4e0b-91be-b36ea00b901d"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-2"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="18380320"/></effectiveTime>
          <value xsi:type="CD" code="A15.0" codeSystem="2.16.840.1.113883.6.90" displayName="Tuberculosis of lung"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="a69a02e0-4185-4209-9b86-9d12a533fd2c"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="18380317"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="9f5a06f5-c136-4193-a6aa-27f81636c523"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-3"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="18380317"/></effectiveTime>
          <value xsi:type="CD" code="E44.0" codeSystem="2.16.840.1.113883.6.90" displayName="Moderate protein-calorie malnutrition"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.9" extension="2014-06-09"/>
    <code code="51847-2" codeSystem="2.16.840.1.113883.6.1" displayName="Evaluation + Plan note"/>
    <title>Assessment and Plan</title>
    <text><list listType="ordered"><item><content styleCode="Bold">Pulmonary tuberculosis, cavitary, smear-positive (A15.0)</content>. Confirmed today, replacing the presenting problem of cough, hemoptysis, and weight loss. No rifampin resistance. He meets the criteria for the four-month regimen: over 12 years old, weight 48.4 kg (at least 40 kg), pulmonary disease only, HIV negative, no prolonged QT history and no QT-prolonging or interacting medicines, normal potassium (4.0), magnesium (2.0), liver tests, and creatinine, no earlier tuberculosis treatment, and specimens sent for susceptibility testing before the first dose. Dr. Kowalczyk-Grant agrees. [S]<list><item>Rifapentine 1200 mg, moxifloxacin 400 mg, isoniazid 300 mg, and pyrazinamide 1000 mg daily with food for eight weeks, then rifapentine, moxifloxacin, and isoniazid for nine weeks, with pyridoxine 50 mg, by video-observed therapy seven days a week.</item><item>Three sputum smears in the third week for the release decision; then monthly sputum until two cultures are negative.</item><item>Liver tests in two to three weeks because of his low weight and albumin; stop the doses and call the same day for yellow eyes, dark urine, vomiting, or abdominal pain.</item><item>Stop moxifloxacin and call for tendon pain; report numbness or tingling in his fingers.</item><item>No mineral supplements, antacids, or zinc products within four hours before or eight hours after the dose.</item></list></item><item><content styleCode="Bold">Moderate protein-calorie malnutrition (E44.0)</content>. BMI 16.7 today. Appetite should return as the infection comes under control. [S]<list><item>First dietitian visit by video this week; supplement drinks in the afternoon and evening, well away from the morning dose.</item></list></item></list><paragraph>Protocol monitoring: items the monitoring protocol calls for at this visit. [S]</paragraph><table><thead><tr><th>Domain</th><th>Measure</th><th>Interval</th><th>Status</th><th>Detail</th></tr></thead><tbody><tr><td>Examination</td><td>Symptom review: cough, sputum, hemoptysis, fever, night sweats</td><td>Every visit</td><td>Completed today</td><td>Cough, one more streak of blood, night sweats; no improvement yet before treatment</td></tr><tr><td>Examination</td><td>Weight, with the pyrazinamide dose checked against the weight band</td><td>Monthly</td><td>Completed today</td><td>48.4 kg: pyrazinamide 1000 mg for the 40 to under 55 kg band</td></tr><tr><td>Medication safety</td><td>Adverse effects: hepatitis symptoms, tendon pain, numbness or tingling, rash, nausea, orange body fluids</td><td>Every visit</td><td>Completed today</td><td>Baseline tendon and nerve examination normal; warning symptoms explained</td></tr><tr><td>Laboratory</td><td>Liver tests (ALT, AST, bilirubin)</td><td>Baseline; repeat for symptoms or risk factors (here at two to three weeks, for low weight and albumin)</td><td>Up to date</td><td>Baseline ALT 18, AST 24, bilirubin 0.5, all normal; repeat ordered for the next visit</td></tr><tr><td>Laboratory</td><td>Potassium, calcium, magnesium, platelets, creatinine</td><td>Baseline, then as indicated</td><td>Up to date</td><td>Baseline potassium 4.0, calcium 9.0, magnesium 2.0, platelets 442 (raised with inflammation), creatinine 0.78</td></tr><tr><td>Medication safety</td><td>Electrocardiogram (QT interval)</td><td>Not routine; only if clinically indicated</td><td>Not indicated</td><td>No QT history, no QT-prolonging medicines, normal potassium and magnesium</td></tr><tr><td>Laboratory</td><td>Sputum acid-fast smear and culture</td><td>Baseline, then monthly until two consecutive cultures are negative</td><td>Completed today</td><td>Three baseline smears 2+, 2+, 1+; cultures pending</td></tr><tr><td>Laboratory</td><td>Nucleic acid amplification test with rifampin resistance</td><td>At baseline</td><td>Completed today</td><td>Mycobacterium tuberculosis complex detected; rifampin resistance not detected</td></tr><tr><td>Laboratory</td><td>Rapid molecular testing for isoniazid and fluoroquinolone resistance</td><td>At baseline</td><td>Ordered</td><td>Sent on the first sample; pending</td></tr><tr><td>Laboratory</td><td>Phenotypic susceptibility (rifampin, isoniazid, pyrazinamide, moxifloxacin)</td><td>At baseline</td><td>Ordered</td><td>On the culture isolate when it grows</td></tr><tr><td>Laboratory</td><td>Interferon-gamma release assay</td><td>At baseline</td><td>Completed today</td><td>Positive; supports, but could not by itself prove or exclude, active tuberculosis</td></tr><tr><td>Laboratory</td><td>HIV test</td><td>At baseline</td><td>Completed today</td><td>HIV-1/2 antigen and antibody negative</td></tr><tr><td>Laboratory</td><td>Hepatitis B and C serology</td><td>At baseline</td><td>Completed today</td><td>Hepatitis B surface antigen and core antibody negative, surface antibody positive (vaccinated); hepatitis C antibody negative</td></tr><tr><td>Imaging</td><td>Chest X-ray</td><td>Baseline; at two months only if baseline cultures were negative; end of treatment optional</td><td>Up to date</td><td>Right upper lobe cavity on X-ray and CT at the first visit</td></tr><tr><td>Medication safety</td><td>Doses observed and the completion clock (56 doses within 70 days, 63 within 84 days, 119 within five months)</td><td>Every visit</td><td>Completed today</td><td>Video-observed therapy set up with the health department; first dose observed in clinic today</td></tr><tr><td>Medication safety</td><td>Drug interactions: rifapentine, and mineral products with moxifloxacin</td><td>With every new medicine or supplement</td><td>Completed today</td><td>No other medicines; mineral products to be kept apart from moxifloxacin; orange urine and tears expected</td></tr><tr><td>Self-management</td><td>Home airborne isolation and the release criteria</td><td>Until three negative smears, clinical improvement, and two weeks of treatment</td><td>Completed today</td><td>Continues at home; lessons online</td></tr><tr><td>Referral</td><td>Report to the health department</td><td>Same day as suspicion and on confirmation</td><td>Completed today</td><td>Suspected case reported at the first visit; confirmation sent today</td></tr><tr><td>Referral</td><td>Contact investigation (students, friends, close contacts)</td><td>Led by the health department from diagnosis</td><td>Referred</td><td>Health department listing his students and other close contacts; their results are not part of his record</td></tr><tr><td>Survey</td><td>Depression screen (PHQ-9)</td><td>At diagnosis, at two months, and at the end of treatment</td><td>Up to date</td><td>7 at the first visit, item 9 scored 0</td></tr><tr><td>Self-management</td><td>Nutrition: dietitian, intake, supplement drinks</td><td>Every visit until weight is restored</td><td>Ordered</td><td>First dietitian visit by video this week</td></tr><tr><td>Laboratory</td><td>Sweat chloride and serum alpha-1 antitrypsin</td><td>Once, to address the alternatives</td><td>Ordered</td><td>Advised by infectious diseases; at the next visit, once he is out of isolation</td></tr><tr><td>Referral</td><td>Infectious diseases review</td><td>At diagnosis, at two months, and at the end of treatment</td><td>Completed today</td><td>Seen today by Dr. Kowalczyk-Grant</td></tr></tbody></table><paragraph>Goal progress:</paragraph><list><item>Complete all 119 doses within five months by video-observed therapy. In progress; target 1838-07-21 [S]</item><item>Sputum culture negative at two months. In progress; target 1838-07-21 [S]</item><item>Return to teaching once the health department confirms he is no longer infectious. In progress; target 1838-04-07 [S]</item><item>Weight back to at least 55 kg by the end of treatment. In progress; target 1838-07-21 [S]</item><item>PHQ-9 below 5 by the end of treatment. In progress; target 1838-07-21 [S]</item></list><paragraph>Guideline basis: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis (2016); Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis - United States, 2022 (2022); An official ATS statement: hepatotoxicity of antituberculosis therapy (2006); Guidelines for the investigation of contacts of persons with infectious tuberculosis: recommendations from the National Tuberculosis Controllers Association and CDC (2005); Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation (2017); American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency (2003); Consensus statement: Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition: characteristics recommended for the identification and documentation of adult malnutrition (undernutrition) (2012); Depression and Suicide Risk in Adults: Screening (2023)</paragraph><paragraph>Follow-up: Release smears in the third week, then review at about two and a half weeks with liver tests, the sweat chloride test, and the alpha-1 antitrypsin level. Call the same day for hepatitis symptoms or tendon pain. Next scheduled visit 1838-04-07: two-and-a-half-week review: release from isolation, return to teaching, liver tests, and tests for cystic fibrosis and alpha-1 antitrypsin deficiency. [S]</paragraph></text>

  </section>
</component>
    </structuredBody>
  </component>
</ClinicalDocument>
